假马齿苋皂苷C
Bacopasaponin C 是一种口服活性的天然糖苷。Bacopasaponin C 可从 Bacopa monniera 中分离。Bacopasaponin C 抑制 Verapamil (HY-14275) 刺激的 P-gp ATP 酶活性,IC50 为 57.83 μg/mL。Bacopasaponin C 对肉瘤具有抗肿瘤活性。Bacopasaponin C 对 Leishmania donovani 具有抗寄生虫活性。
假马齿苋皂苷C (标准品)
Bacopasaponin C (Standard) 是 Bacopasaponin C (HY-N6015) 的分析标准品。本产品用于研究及分析应用。Bacopasaponin C 是一种口服活性的天然糖苷。Bacopasaponin C 可从 Bacopa monniera 中分离。Bacopasaponin C 抑制 Verapamil (HY-14275) 刺激的 P-gp ATP 酶活性,IC50 为 57.83 μg/mL。Bacopasaponin C 对肉瘤具有抗肿瘤活性。Bacopasaponin C 对 Leishmania donovani 具有抗寄生虫活性。
Dihydroflavokawin B 是一种选择性 COX-1 抑制剂,其 IC50 为 1.22 μM。Dihydroflavokawin B 可微弱抑制 COX-2 和 5-LOX。Dihydroflavokawin B 可抑制 Leishmania panamensis 和 Leishmania braziliensis 的前鞭毛体形式。Dihydroflavokawin B 可抑制由花生四烯酸、血小板活化因子和二磷酸腺苷诱导的兔血小板聚集。Dihydroflavokawin B 具有体外抗炎活性。Dihydroflavokawin B 可用于利什曼病的研究。
竹红菌甲素 (标准品)
Hypocrellin A (Standard)是 Hypocrellin A 的分析标准品。本产品用于研究及分析应用。Hypocrellin A 是一种 PKC 抑制剂,通过逆转高糖对内皮素 (ET-1) 的表达来发挥抗糖尿病活性。Hypocrellin A 也是一种具有抗癌,抗菌和抗病毒活性,特别是针对人类免疫缺陷病毒(HIV)的光动力疗法 (PDT) 光敏剂。此外,Hypocrellin-A 还拥有抗利什曼原虫活性 (IC50=0.27
假马齿苋皂苷C
Bacopasaponin C 是一种口服活性的天然糖苷。Bacopasaponin C 可从 Bacopa monniera 中分离。Bacopasaponin C 抑制 Verapamil (HY-14275) 刺激的 P-gp ATP 酶活性,IC50 为 57.83 μg/mL。Bacopasaponin C 对肉瘤具有抗肿瘤活性。Bacopasaponin C 对 Leishmania donovani 具有抗寄生虫活性。
假马齿苋皂苷C (标准品)
Bacopasaponin C (Standard) 是 Bacopasaponin C (HY-N6015) 的分析标准品。本产品用于研究及分析应用。Bacopasaponin C 是一种口服活性的天然糖苷。Bacopasaponin C 可从 Bacopa monniera 中分离。Bacopasaponin C 抑制 Verapamil (HY-14275) 刺激的 P-gp ATP 酶活性,IC50 为 57.83 μg/mL。Bacopasaponin C 对肉瘤具有抗肿瘤活性。Bacopasaponin C 对 Leishmania donovani 具有抗寄生虫活性。
竹红菌甲素 (标准品)
Hypocrellin A (Standard)是 Hypocrellin A 的分析标准品。本产品用于研究及分析应用。Hypocrellin A 是一种 PKC 抑制剂,通过逆转高糖对内皮素 (ET-1) 的表达来发挥抗糖尿病活性。Hypocrellin A 也是一种具有抗癌,抗菌和抗病毒活性,特别是针对人类免疫缺陷病毒(HIV)的光动力疗法 (PDT) 光敏剂。此外,Hypocrellin-A 还拥有抗利什曼原虫活性 (IC50=0.27
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.